FLGT CIK: 1674930

Fulgent Genetics, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.61
FY22:
0.63
FY23:
0.51
FY24:
0.35
FY25:
0.55
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.67
FY22:
0.76
FY23:
0.73
FY24:
0.87
FY25:
0.66
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.28
FY22:
1.39
FY23:
1.24
FY24:
1.22
FY25:
1.21

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.11
FY22:
0.09
FY23:
0.07
FY24:
0.07
FY25:
0.08
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.03
FY23:
0.03
FY24:
0.02
FY25:
0.02
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.16
FY22:
1.27
FY23:
1.14
FY24:
1.13
FY25:
1.11

All amounts in billions USD Data source:SEC EDGAR